Ptc Therapeutics (PTCT) Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Non-Current Assets history runs 15 years deep, the most recent figure standing at $615.1 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 81.46% year-over-year to $615.1 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 24.45% YoY), while the FY2025 annual figure was $624.8 million, up 84.04% from the prior year.
• Non-Current Assets was $615.1 million for Q1 2026 at Ptc Therapeutics, down from $624.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.1 billion in Q2 2022 to a low of $339.0 million in Q1 2025.
• Historically, Non-Current Assets has averaged $706.0 million across 5 years, with a median of $635.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 49.86% in 2024, then surged 84.04% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $1.0 billion in 2022, then plunged by 33.08% to $677.1 million in 2023, then slumped by 49.86% to $339.5 million in 2024, then jumped by 84.04% to $624.8 million in 2025, then dropped by 1.56% to $615.1 million in 2026.
• The last three Non-Current Assets figures came in at $615.1 million (Q1 2026), $624.8 million (Q4 2025), and $635.9 million (Q3 2025), per Business Quant data.